Savior Lifetec Corporation (4167.TWO)
TWD 16.8
(3.7%)
TWD 16.8
(3.7%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -812.54 Million TWD | -187.4% |
| 2022 | -282.72 Million TWD | -161.48% |
| 2021 | 459.83 Million TWD | 66.39% |
| 2020 | 276.37 Million TWD | -69.15% |
| 2019 | 895.78 Million TWD | 25.44% |
| 2018 | 714.12 Million TWD | 163.64% |
| 2017 | 270.87 Million TWD | 39.7% |
| 2016 | 193.88 Million TWD | -80.51% |
| 2015 | 994.79 Million TWD | -10.05% |
| 2014 | 1.1 Billion TWD | 169.05% |
| 2013 | 411.06 Million TWD | -13.92% |
| 2012 | 477.51 Million TWD | 14.33% |
| 2011 | 417.64 Million TWD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -913.94 Million TWD | -12.48% |
| 2024 Q2 | -1.02 Billion TWD | -12.39% |
| 2023 Q3 | -861.41 Million TWD | -0.32% |
| 2023 Q1 | -358.21 Million TWD | -26.7% |
| 2023 Q2 | -858.66 Million TWD | -139.7% |
| 2023 FY | -812.54 Million TWD | -187.4% |
| 2023 Q4 | -812.54 Million TWD | 5.67% |
| 2022 Q2 | 419.42 Million TWD | 11.7% |
| 2022 Q3 | -288.54 Million TWD | -168.8% |
| 2022 Q4 | -282.72 Million TWD | 2.02% |
| 2022 Q1 | 375.49 Million TWD | -18.34% |
| 2022 FY | -282.72 Million TWD | -161.48% |
| 2021 Q3 | 419.77 Million TWD | -10.09% |
| 2021 Q1 | 295.58 Million TWD | 6.95% |
| 2021 Q2 | 466.85 Million TWD | 57.94% |
| 2021 FY | 459.83 Million TWD | 66.39% |
| 2021 Q4 | 459.83 Million TWD | 9.54% |
| 2020 Q1 | 1 Billion TWD | 11.86% |
| 2020 Q2 | 238.12 Million TWD | -76.24% |
| 2020 Q3 | 103.64 Million TWD | -56.48% |
| 2020 FY | 276.37 Million TWD | -69.15% |
| 2020 Q4 | 276.37 Million TWD | 166.66% |
| 2019 Q2 | 514.34 Million TWD | -62.37% |
| 2019 Q4 | 895.78 Million TWD | -5.39% |
| 2019 FY | 895.78 Million TWD | 25.44% |
| 2019 Q1 | 1.36 Billion TWD | 91.39% |
| 2019 Q3 | 946.81 Million TWD | 84.08% |
| 2018 Q1 | 554.84 Million TWD | 104.83% |
| 2018 FY | 714.12 Million TWD | 163.64% |
| 2018 Q4 | 714.12 Million TWD | -8.9% |
| 2018 Q3 | 783.88 Million TWD | 40.34% |
| 2018 Q2 | 558.55 Million TWD | 0.67% |
| 2017 Q3 | 350.53 Million TWD | -43.53% |
| 2017 FY | 270.87 Million TWD | 39.7% |
| 2017 Q4 | 270.87 Million TWD | -22.73% |
| 2017 Q1 | 500.65 Million TWD | 158.22% |
| 2017 Q2 | 620.78 Million TWD | 23.99% |
| 2016 Q4 | 193.88 Million TWD | -33.96% |
| 2016 Q3 | 293.57 Million TWD | 17.0% |
| 2016 Q2 | 250.92 Million TWD | -77.74% |
| 2016 Q1 | 1.12 Billion TWD | 13.31% |
| 2016 FY | 193.88 Million TWD | -80.51% |
| 2015 Q3 | 853.43 Million TWD | -18.09% |
| 2015 Q4 | 994.79 Million TWD | 16.56% |
| 2015 Q2 | 1.04 Billion TWD | -18.83% |
| 2015 FY | 994.79 Million TWD | -10.05% |
| 2015 Q1 | 1.28 Billion TWD | 16.07% |
| 2014 Q3 | 1.14 Billion TWD | 20.99% |
| 2014 Q1 | 69.72 Million TWD | -83.04% |
| 2014 Q2 | 943.74 Million TWD | 1253.6% |
| 2014 FY | 1.1 Billion TWD | 169.05% |
| 2014 Q4 | 1.1 Billion TWD | -3.14% |
| 2013 Q4 | 411.06 Million TWD | 0.0% |
| 2013 FY | 411.06 Million TWD | -13.92% |
| 2013 Q1 | 520.78 Million TWD | 9.06% |
| 2013 Q2 | 511.39 Million TWD | -1.8% |
| 2012 Q2 | 686.81 Million TWD | 0.0% |
| 2012 FY | 477.51 Million TWD | 14.33% |
| 2012 Q4 | 477.51 Million TWD | 291.71% |
| 2012 Q3 | -249.08 Million TWD | -136.27% |
| 2011 Q4 | 417.64 Million TWD | 0.0% |
| 2011 FY | 417.64 Million TWD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| SYN-TECH Chem. & Pharm. Co., Ltd. | -264.16 Million TWD | -207.585% |
| Sagittarius Life Science Corp | -120.57 Million TWD | -573.918% |
| NeoCore Technology Co., Ltd. | -196.39 Million TWD | -313.725% |
| GeneReach Biotechnology Corp. | 40.26 Million TWD | 2117.938% |
| Genomics BioSci & Tech. Co.,Ltd. | 30.57 Million TWD | 2757.28% |
| Visgeneer Inc. | 31.28 Million TWD | 2697.312% |
| Sunmax Biotechnology Co., Ltd. | -680.6 Million TWD | -19.385% |
| G&E Herbal Biotechnology Co., Ltd. | -134.25 Million TWD | -505.237% |
| Neith Corporation | -150.31 Million TWD | -440.575% |
| TaiwanJ Pharmaceuticals Co., Ltd. | -57.65 Million TWD | -1309.246% |
| Enimmune corporation | -314.15 Million TWD | -158.641% |
| TaiRx, Inc. | -147.86 Million TWD | -449.502% |
| EirGenix Inc. | -4.58 Billion TWD | 82.29% |
| BioLASCO Taiwan Co., Ltd. | -84.76 Million TWD | -858.606% |
| Sunny Pharmtech Inc. | 120.87 Million TWD | 772.24% |
| BioGend Therapeutics Co., Ltd. | -317.41 Million TWD | -155.985% |
| Feng Chi Biotech Corp. | -19.81 Million TWD | -4001.06% |
| Lukas Biomedical Inc. | 50.75 Million TWD | 1700.912% |
| RBC Bioscience Corporation | 422.18 Million TWD | 292.461% |
| BiOptic Inc. | 12.59 Million TWD | 6552.851% |
| Anti-Microbial Savior BioteQ Co., Ltd | -77.04 Million TWD | -954.648% |
| Shine-On BioMedical Co.,Ltd. | -101.48 Million TWD | -700.645% |
| Great Novel Therapeutics Biotech & Medicals | -165.17 Million TWD | -391.926% |
| Syngen Biotech Co.,Ltd. | 314.87 Million TWD | 358.054% |
| Mycenax Biotech Inc. | 207 Million TWD | 492.516% |
| Medigen Vaccine Biologics Corporation | 621.53 Million TWD | 230.731% |
| Bio Preventive Medicine Corp. | 31.8 Million TWD | 2654.444% |
| Level Biotechnology Inc. | -453.9 Million TWD | -79.012% |
| TaiMed Biologics Inc. | 499.84 Million TWD | 262.558% |
| GlycoNex Incorporation | -148.56 Million TWD | -446.92% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 137.99 Million TWD | 688.821% |
| SynCore Biotechnology Co.,Ltd | -262.58 Million TWD | -209.444% |
| Lin BioScience, Inc. | -3.21 Billion TWD | 74.752% |
| BRIM Biotechnology, Inc. | -944.4 Million TWD | 13.962% |
| VBI | -25.31 Million TWD | -3109.603% |
| CHO Pharma, Inc. | -203.79 Million TWD | -298.712% |
| Advagene Biopharma Co., Ltd. | -64.32 Million TWD | -1163.262% |
| NaviFUS Corp. | -123.12 Million TWD | -559.912% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | 74.05 Million TWD | 1197.275% |
| Sinew Pharma Inc. | -160.34 Million TWD | -406.747% |
| Andros Pharmaceuticals Co.,Ltd | -241.89 Million TWD | -235.91% |
| Greenyn Biotechnology Co., Ltd | -337.37 Million TWD | -140.843% |
| Lumosa Therapeutics Co., Ltd. | -412.63 Million TWD | -96.914% |
| AP Biosciences Inc | -196.52 Million TWD | -313.449% |
| Medigen Biotechnology Corp. | 688.73 Million TWD | 217.976% |
| 3D Global Biotech Inc. | -11.43 Million TWD | -7004.512% |
| Pharmosa Biopharm Inc. | -829.69 Million TWD | 2.067% |
| Intech Biopharm Corporation | 1.35 Billion TWD | 159.864% |
| Oneness Biotech Co., Ltd. | -414.87 Million TWD | -95.851% |
| Eusol Biotech Co.,Ltd. | -209.33 Million TWD | -288.149% |
| TWi Biotechnology, Inc. | -143.86 Million TWD | -464.803% |
| Ever Supreme Bio Technology Co., Ltd | -330.54 Million TWD | -145.821% |
| TCI GENE Inc. | -689.25 Million TWD | -17.888% |
| MegaPro Biomedical Co., Ltd | -118.93 Million TWD | -583.165% |
| Senhwa Biosciences, Inc. | -1.3 Billion TWD | 37.936% |
| Taiwan Bio Therapeutics Co., Ltd | 20.48 Million TWD | 4066.914% |
| NatureWise Biotech & Medicals Corporation | -101.87 Million TWD | -697.627% |
| PharmaEngine, Inc. | -860.8 Million TWD | 5.607% |
| TaiGen Biopharmaceuticals Holdings Limited | -299.96 Million TWD | -170.877% |
| OBI Pharma, Inc. | -398.22 Million TWD | -104.042% |
| Meribank Biotech Co., Ltd | -365.41 Million TWD | -122.359% |
| Acepodia, Inc. | -6.02 Billion TWD | 86.503% |
| Caliway Biopharmaceuticals Co., Ltd. | -3.4 Billion TWD | 76.114% |